METFORMIN-ALTERNATIVE DRUG FOR MEDICATION INSULINE RESITENCE AMONG THE INVOLVED PEOPLES WITH DIABETES TYPE 2

S. Pajović ,
S. Pajović

Internal clinic, Medical faculty Priština , Kosovska Mitrovica , Kosovo*

A. Jovanović ,
A. Jovanović

Internal clinic, Medical faculty Priština , Kosovska Mitrovica , Kosovo*

T. Novaković
T. Novaković

Internal clinic, Medical faculty Priština , Kosovska Mitrovica , Kosovo*

Published: 01.12.2006.

Volume 34, Issue 2 (2006)

pp. 111-112;

https://doi.org/10.70949/pramed200602166P

Abstract

Diabetes mellitus is the most frequently chronical disease.In the relation on the degree of affection populations (over 150 000 000 peoples), was able speak about pandemic of this illnesses. In the orgin of insulin-indipendent diabetes mellitus, the primary role has the insuline resistence. Date from literature gives the evidence that the metformin is a drug for insuline resitence. Behaind the rest, has been proved that metformin, decrease risk factors for beginning complications this illnesses

Keywords

References

1.
Group UKPDS. Effect of intensive blood glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34. Lancet. 352:854–65.
2.
Group UKPDS. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and the risk of complications in patients with type 2 diabetes (UKPDS 37. Diabetes Care. 22:1125–36.
3.
Fronzo RA. Metformin: A review of its metabolic effects. N Engl J Med. 333:541–9.
4.
Garber AJ, Duncan TG, Goodman AM. Efficacy of metformin in type 2 diabetes: Results of a double-blind, placebo-controlled, dose-response trial. Am J Med. 103:491–7.
5.
Kažić T. Lekovi za endokrine bolesti. In: Gotovi lekovi Integra; 2001 VIII izdanje. p. 67–80.
6.
Đorđević PB. Lečenje diabetes mellitusa peroralnim sredstvima. In: Interna medicina Zavod za udžbenike i nastavna sredstva.
7.
Krentz AJ, Bailey CJ. Type 2 diabetes in practice: Pharmacological treatment II.

Citation

Copyright

Article metrics

Google scholar: See link

The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Most read articles

Indexed by